Wellington Management Group LLP Buys 165,565 Shares of Avantor, Inc. (NYSE:AVTR)

Wellington Management Group LLP lifted its position in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 19.3% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,022,101 shares of the company's stock after buying an additional 165,565 shares during the period. Wellington Management Group LLP owned about 0.15% of Avantor worth $26,442,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the company. Cetera Advisors LLC purchased a new stake in Avantor during the first quarter valued at about $249,000. SG Americas Securities LLC grew its position in Avantor by 222.0% during the 2nd quarter. SG Americas Securities LLC now owns 19,996 shares of the company's stock worth $424,000 after acquiring an additional 13,786 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its stake in Avantor by 2.8% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 26,921 shares of the company's stock worth $571,000 after purchasing an additional 733 shares during the period. Swedbank AB lifted its position in Avantor by 1.3% in the second quarter. Swedbank AB now owns 107,182 shares of the company's stock valued at $2,272,000 after purchasing an additional 1,327 shares during the last quarter. Finally, Assenagon Asset Management S.A. lifted its position in Avantor by 403.4% in the second quarter. Assenagon Asset Management S.A. now owns 133,515 shares of the company's stock valued at $2,831,000 after purchasing an additional 106,992 shares during the last quarter. Institutional investors own 95.08% of the company's stock.

Avantor Stock Down 0.9 %

AVTR stock traded down $0.20 during midday trading on Friday, hitting $22.33. The stock had a trading volume of 3,578,948 shares, compared to its average volume of 6,472,614. The business has a 50-day moving average of $22.47 and a two-hundred day moving average of $23.53. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06. The firm has a market cap of $15.20 billion, a price-to-earnings ratio of 48.54, a price-to-earnings-growth ratio of 2.75 and a beta of 1.29. Avantor, Inc. has a 52-week low of $19.59 and a 52-week high of $28.00.

Analysts Set New Price Targets

Several brokerages have recently issued reports on AVTR. UBS Group cut their target price on shares of Avantor from $30.00 to $29.00 and set a "buy" rating on the stock in a report on Tuesday, October 8th. Robert W. Baird decreased their price objective on shares of Avantor from $27.00 to $26.00 and set an "outperform" rating on the stock in a research report on Monday, October 28th. Wells Fargo & Company dropped their target price on shares of Avantor from $30.00 to $28.00 and set an "overweight" rating for the company in a report on Monday, October 28th. Barclays reduced their price target on Avantor from $28.00 to $25.00 and set an "overweight" rating on the stock in a report on Friday, October 25th. Finally, Royal Bank of Canada reiterated an "outperform" rating and issued a $34.00 price objective on shares of Avantor in a report on Thursday, September 26th. Two equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $27.69.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.